Regentis Biomaterials (RGNT) Cash & Current Investments (2024 - 2025)
Regentis Biomaterials' (RGNT) quarterly Cash & Current Investments came in at $7.4 million in Q4 2025, up 3121.83% year-on-year from $229000.0 in Q4 2024, and up 3121.83% on a QoQ basis from $229000.0 in Q4 2024.
Regentis Biomaterials (RGNT) Cash & Current Investments (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Cash & Current Investments data on file, last reported at $7.4 million in Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 3121.83% year-over-year to $7.4 million in Q4 2025; TTM through Dec 2025 was $7.4 million, a 3121.83% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 3121.83% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $7.4 million, up from $229000.0 in the prior quarter.
- Over the last five years, Cash & Current Investments for RGNT reached as high as $7.4 million in Q4 2025 and fell as low as $229000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Regentis Biomaterials | 1.14 Mn | -6.24 Mn | - | 7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 229,000.00 |